Category: Gene Therapy
Global Gene Therapy
-
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
... and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis ... Read More
-
Gene Vector Market - By Vector (Plasmid DNA, Adeno-Associated Viral, Retroviral), By Application (Gene Therapy, Vaccinology), By Disease (Oncology, Genetic, Infectious) By End-user (CDMO, CRO, Pharma & Biotech Companies), Global Forecast 2023-2032
... Market size will expand considerably through 2032. Growing number of clinical trials will pave the way for industry growth. Many clinical trials explore the potential of combination therapies, where gene therapy is combined with other ... Read More
-
Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2023(Status and Outlook)
... The Global Viral Vectors and Plasmid DNA Manufacturing Market Size was estimated at USD 608.00 million in 2022 and is projected to reach USD 1936.77 million by 2029, exhibiting a CAGR of 18.00% during the ... Read More
-
Global Gene Therapy On Cardiovascular Disease Market Research Report 2023(Status and Outlook)
... doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential ... Read More
-
Global Viral Vector and Plasmid DNA Market Research Report 2023(Status and Outlook)
... for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory operations.In recent years, global viral vector and plasmid DNA manufacturing has ... Read More
-
Global Gene Therapy Market Research Report 2023(Status and Outlook)
... therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier ... Read More
-
Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2023(Status and Outlook)
... The Global Viral Vectors and Plasmid DNA Manufacturing Market Size was estimated at USD 608.00 million in 2022 and is projected to reach USD 1936.77 million by 2029, exhibiting a CAGR of 18.00% during the ... Read More
-
Global Gene Therapy Market Report and Forecast 2023-2031
... The market size is anticipated to grow at a CAGR of 22.8% during the forecast period of 2023-2031 to achieve a value of USD 40.39 billion by 2031. Gene Therapy Introduction Gene therapy is a ... Read More
-
Global Thalassemia Market Size study & Forecast, by Therapeutic Class (Iron Chelating Drugs), by Pipeline (Gene Therapy) and Regional Analysis, 2022-2029
... to grow with a healthy growth rate of more than 5% over the forecast period 2022-2029. According to Centers for Disease Control and Prevention - Thalassemia can be defined as an inherited blood disorder caused ... Read More
-
Gene Therapy Global Market Opportunities And Strategies To 2032
... need to assess the global gene therapy market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 ... Read More
-
Viral Vector Production Market (Vector Type: Adenovirus, Adeno-associated Virus, Retroviruses, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Viral Vector Production Market for the period 2017–2031, considering 2023 as the base year and 2031 ... Read More
-
Nucleic Acid Therapeutics CDMO Market - A Global and Regional Analysis: Focus on Chemical Synthesis Method, Product, Technology, End User, and Region - Analysis and Forecast, 2023-2033
... The global nucleic acid therapeutics CDMO market was valued at $3.88 billion in 2022 and is expected to reach $14.19 billion by 2033, growing at a CAGR of 12.55% during the forecast period 2023-2033. The ... Read More
-
Global Huntington’s Disease Treatment Market Report and Forecast 2023-2031
... to grow at a rate of 16.0% in the forecast period of 2023-2031. Driven by the growing demand and increasing R&D activities, the market is anticipated to be worth USD 1.52 billion by 2031. Huntington’s ... Read More
-
2023 Global: Cancer Gene Therapy - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
Global Rare Disease Treatment Market Report and Forecast 2023-2031
... prevalence of rare diseases worldwide, coupled with the growing investment in research and development activities, is driving the growth of the market. The global rare diseases treatment market is likely to grow at a CAGR ... Read More
-
Global Cell and Gene Therapy Market Report and Forecast 2023-2031
... of 2023-2031, driven by the increasing prevalence of chronic diseases, advancements in gene editing technologies, and the rising demand for personalized medicine. The market is expected to grow at a CAGR of 23.2% during the ... Read More
-
Global Adeno-Associated Virus Vector-Based Gene Therapy Market Report and Forecast 2023-2031
... the forecast period of 2023-2031, driven by the rising prevalence of genetic disorders and the increasing investments in research and development activities. The market is projected to grow at a CAGR of 18.5% during the ... Read More
-
Gene Switch Market - Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression and Other Applications), Type of Target Therapy (CAR-T Cell Therapies, Gene Therapies and Other Therapies), Type of Payment Model Employed (Upfront Payments and Milestone Payments) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
... Model Employed (Upfront Payments and Milestone Payments) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 INTRODUCTION Driven by numerous developmental breakthroughs and encouraging clinical ... Read More
-
Cell & Gene Therapy Manufacturing Service Market: Trends, Opportunities and Competitive Analysis [2023-2028]
... promising with opportunities in cell processing, cell banking, process development, fill & finish operations, analytical and quality testing, raw material testing, and vector production. The global cell & gene therapy manufacturing service market is expected ... Read More
-
Recombinant Cell Culture Supplements Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2018-2028F, By Product (Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Albumin, Recombinant Collagen, Recombinant Transferrin, Recombinant Trypsin, Others), By Application {Regenerative Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies) and Bio-Production(Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)}, By Expression System (Mammalian Expression System, E. coli Expression System, Yeast Expression System, Others), By End User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies), By Region and Competition
... Cell Therapies, Cell Therapies, Gene Therapies) and Bio-Production(Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines, Others)}, By Expression System (Mammalian Expression System, E. coli Expression System, Yeast Expression System, Others), By End User (Academic & Research Institutions, ... Read More
-
Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... at lower cost coupled with increasing aesthetic consciousness among the population significantly increases the demand for cancer gene therapy across different parts of the globe. Besides, growing awareness about the advantages of using gene therapy ... Read More
-
Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
... Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others) The biopharmaceuticals market is expected to grow from US$ 3,29,966.22 ... Read More
-
Global Cell and Gene Therapy Bioassay Services Market Growth (Status and Outlook) 2023-2029
... in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Cell and Gene Therapy Bioassay Services is estimated to increase from US$ million in 2022 ... Read More
-
Global Gene Therapy Market Size study & Forecast, by Vector [Viral VectorsNon-viral VectorsBy Delivery Method (In Vivo, Ex Vivo) by Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Others), By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors, Others), and Regional Analysis, 2022-2029
... (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors, Others), and Regional Analysis, 2022-2029 Global Gene Therapy Market is valued at approximately USD 6.2 billion in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
Global Gene Therapy for CNS Disorders Market Growth (Status and Outlook) 2023-2029
... be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them ... Read More
Research Assistance
